课题基金 / 基金详情

Mechanisms of cisplatin resistance and its reversal in urogential carcinoma

Mechanisms of cisplatin resistance and its reversal in urogential carcinoma
泌尿生殖癌顺铂耐药机制及其逆转
批准号:
09671635
负责人:
KOGA Hirofumi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

KOGA Hirofumi的其他基金

相似基金

相关文献

中文摘要
翻译
1.建立顺铂耐药的膀胱癌细胞株,探讨顺铂获得性耐药的机制。结论:1.药物蓄积减少、细胞内谷胱甘肽增多、谷胱甘肽S转移酶π和γ谷氨酰半胱氨酸合成酶基因表达增加等多种机制参与了顺铂耐药的获得。探讨人膀胱癌细胞株对顺铂的内源性耐药机制。结果表明,细胞内铂的蓄积与细胞内的内阻有关。我们进行了前瞻性随机研究,以观察P-糖蛋白介导的多药耐药的化疗增敏剂维拉帕米能否增强阿霉素对浅表性膀胱癌经尿道电切术后膀胱内复发的预防作用。我们发现在预防复发方面,维拉帕米和阿霉素联合膀胱内灌注较单用阿霉素有更大的益处。我们对新合成的二氢吡啶和咪唑并噻唑类化合物进行了筛选,以确定它们是否能够克服多药耐药,并找到了几个有用的试剂。我们从人睾丸生殖细胞肿瘤细胞系中建立了顺铂耐药生殖细胞肿瘤细胞系,并将其注射到结节小鼠的原位(睾丸)内,建立了一种实用的淋巴转移模型。
英文摘要
1. The mechanisms of acquired resistance to cisplatin was examined using newly established cisplatin resistant bladder cancer cell lines. Multiple mechanisms, including decreased drug accumulation, increased intracellular glutathione and increased expression of glutathione S-transferase π and γ-glutamylcysteine synthetase genes, contributed to the acquisition of cisplatin resistance.2. The mechanisms of intrinsic resistance to cisplatin in human bladder cancer cell lines was investigated. It was revealed that accumulation of intracellular platinum was correlated with intrinsic resistance.3. We performed the prospective randomized study to examined whether verapamil, a chemosensitizing agent of P-glycoprotein-mediated multidrug resistance, could enhance the prophylactic effect of doxorubicin on intravesical recurrence after transurethral resection of superficial bladder cancer. We found that intravesical instillation of verapamil and doxorubicin had a significantly greater beneficial effect than that of doxorubicin alone for preventing recurrence.4. We screened newly synthesized dihydropyridine and imidazothiazole derivatives to determine whether they might be able to overcome multidrug resistance, and found several useful agents.5. We established a cisplatin resistant germ cell tumor cell line from human testicular germ cell tumor cell line and also established an useful model of lymphnode metastasis by injecting the cells into orthotopic site (testis) of node mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Naito S: "Prophylactic intraversical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer : a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone"Cancer Chemotherapy Phar
Naito S:“针对浅表性膀胱癌经尿道切除术后复发的预防性灌注化疗:阿霉素加维拉帕米与单用阿霉素的随机对照试验”癌症化疗 Phar
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
内藤誠二: "尿路性器癌における抗癌剤感受性規定因子の分子生物学的解析"第17回浜松カンファランス.泌尿器科学の最近の進歩 Recent Advances in Urology. 17-22 (1999)
Seiji Naito:“泌尿生殖癌抗癌药物敏感性决定因素的分子生物学分析”,第 17 届滨松泌尿学会议,17-22 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Naito S: "Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1-"Oncology Research. 10(3). 123-132 (1998)
Naito S:“开发新型逆转剂、咪唑并噻唑衍生物,靶向 MDR1-”肿瘤学研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Koga H: "Accumulation of intracellular platinum is correlated with intrinsic cisplastin resistance in human bladder cancer cell lines"International Journal of Urology. (in press).
Koga H:“细胞内铂的积累与人膀胱癌细胞系的内在顺铂耐药性相关”《国际泌尿学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification of Drug Resistance Gene by Microarray and Elucidation of Mechanism of Drug Resistance in Urogenital Cancer
  • 批准号:
    14571506
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.5万
  • 财政年份:
    2002
  • 负责人:
    KOGA Hirofumi
  • 依托单位:
海外基金